The laboratory of Physiopharmacology is affiliated with the Faculty of Medicine and Health Sciences and the Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, and represents one joint research group that bundles its expertise to focus on cardiovascular disease. 

Key publications

  • The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling. Dugaucquier et al. Am J Physiol Heart Circ Physiol. 2020; 319: H443-H455.
  • Partial inhibition of glycolysis reduces atherogenesis independent of intraplaque neovascularization in mice. Perrotta et al. Arterioscler Thromb Vasc Biol. 2020; 40:1168-1181.
  • Autophagy as an emerging therapeutic target for age-related vascular pathologies. De Munck et al. Expert Opin Ther Targets. 2020; 24: 131-145.

Research consortia

The research group Physiopharmacology is part of the Infla-Med Research Consortium of Excellence and coordinates the INSPIRE H2020 PhD project.